Point72 Asset Management
TRAW icon

Point72 Asset Management’s Traws Pharma TRAW Stock Holding History

Point72 Asset Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-645
Closed -$205K – 1306
2019
Q3 		$205K Hold
645
– – ﹤0.01% 905
2019
Q2 		$689K Hold
645
– – ﹤0.01% 805
2019
Q1 		$798K Hold
645
– – ﹤0.01% 841
2018
Q4 		$510K Hold
645
– – ﹤0.01% 873
2018
Q3 		$1.77M Buy
645
+5
+0.8% +$12.8K 0.01% 779
2018
Q2 		$1.46M Buy
+640
New +$1.86M 0.01% 796

Other funds holding TRAW

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HWA
Hillcrest Wealth Advisors Hazlet, New Jersey $279M AUM 21.72% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management's TRAW Position: Q4 2019 in Review

Point72 Asset Management sold out of Traws Pharma (TRAW) in Q4 2019, closing a stake of 645 shares — an estimated $205K sold.

Point72 Asset Management first reported a position in TRAW in Q2 2018 and held it in 6 quarters. The position peaked at $1.77M in Q3 2018. 18 funds tracked by Wall St. Rank hold TRAW as of Q4 2019.

  • Point72 Asset Management reported no remaining Traws Pharma position as of Q4 2019 after selling out during the quarter.
  • Point72 Asset Management sold 645 Traws Pharma shares in Q4 2019, an estimated $205K.
  • Point72 Asset Management first reported a position in Traws Pharma in Q2 2018 and held it in 6 quarters.
  • Point72 Asset Management's Traws Pharma position peaked at $1.77M in Q3 2018.
  • 18 funds tracked by Wall St. Rank held Traws Pharma as of Q4 2019.

Based on Point72 Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.